Charvet Lab | NYU Langone Health

Skip to Main Content

Charvet Lab

Advancing technology to provide accessible symptom monitoring and management to those living with MS and other neurological conditions.

We are dedicated to investigating new approaches to manage symptoms of neurological conditions and to find treatments that can improve the daily lives of our patients.


Our lab is developing the use of noninvasive brain stimulation therapies and other emerging technologies to reduce symptom burden and to restore cognitive and motor function.

Transcranial Direct Current Stimulation (tDCS)

Transcranial direct current stimulation (tDCS) is a type of noninvasive brain stimulation currently under investigation for use in symptom management and rehabilitation. The treatment is delivered in daily sessions, and tDCS is thought to have the most benefit when repeatedly administered.

If you would like to learn more about our clinical tDCS telehealth program, or if you are seeking tDCS for treatment or interested in learning more about our research, email us at or call 929-455-5126.

Current patients can access tDCS program information online (login and password required).

tDCS Clinical Services

At NYU Langone’s tDCS Program, we provide tDCS instruction and loan all equipment for home use, and can guide patients to use it to augment their therapeutic training activity, all done from the comfort of your own home. We tailor the tDCS setup (including electrode placement and stimulation intensity), as well as associated training activities, to your individual needs, and can also partner with other therapists to add stimulation to an ongoing rehabilitation program.

At each session, we connect with you in real time using videoconference through NYU Langone’s Virtual Health platform, accessed through the NYU Langone Health app.

You can email us with questions at or call 929-455-5126.

Woman wearing transcranial direct current stimulation headset
The tDCS device delivers current that is passed through electrodes placed on the scalp. We use a headset to hold the electrodes (enclosed in sponges) in position.

tDCS Research

We have developed a method to deliver daily tDCS sessions to patients and study participants in their homes using telemedicine. With our method, called remotely supervised tDCS (or RS-tDCS), we have several ongoing areas of research:

  • We are focused on targeting symptoms such as fatigue in MS and other neurological conditions. Many of our studies are also evaluating whether tDCS can improve rehabilitative training outcomes. We pair tDCS with training devices to ameliorate cognitive or motor impairments.
  • We are also investigating the benefit of tDCS, delivered at home, as a treatment for major depression.
  • Other studies are investigating how tDCS works, using neuroimaging to measure its effect in the brain and to determine what might predict benefit.

If you are interested in learning more about tDCS or RS-tDCS, please complete this form. (Please note that Internet Explorer users should consider disabling their ad blocker or using a different browser to properly access the form.)

Advances in Noninvasive Brain Stimulation Technologies

We are focused on evaluating the advancing technical developments for tDCS and beyond. We are expanding the options for noninvasive brain stimulation by testing new approaches such as an innovative transcranial magnetic stimulation device that offers features for remote at-home treatments. We currently have pilot studies for use of this and other new approaches underway, with the goal of having many stimulation therapy options to benefit our patients.

Telehealth: Assessment, Monitoring, and Management

We are leaders in the delivery of telehealth services for both clinical and research use. We have established the use of tDCS at home through live videoconference supervision (known as remotely supervised tDCS, or RS-tDCS).

In addition, our lab is evaluating a range of devices and technologies to both monitor and manage a range of cognitive, motor, and psychological symptoms that many patients experience. We also use technologies from Cogstate to precisely measure cognitive functioning, as well as sensors from RunScribe and G-Walk to capture walking and balance assessments both onsite and remotely.

We are developing novel prototypes and partnering with innovative companies to bring the best of these advances to our patients. These includes technologies from partner companies that can provide cognitive and physical exercises at home such as Posit Science, RehaCom, and Tyromotion, and digital health options targeting emotional distress such as Personal Zen and The 10 Minute Mind.

Virtual Reality (VR)

Virtual reality (VR) is a computer-based application that places users into a simulated three-dimensional environment. The engaging qualities of VR, which can include high-resolution images, surround sound audio, binocular overlap, haptic feedback, and tracking headset perspective, can construct realistic virtual environments for patients. Through headset movement or use of hand controllers, sensors, and trackers, VR results in an experience of sensory immersion with the option for interaction in real-time.

VR can be used as a treatment for individuals with neurological disorders by distracting from acute symptoms, such as pain or fatigue, as well as training individuals to use therapeutic self-management strategies and enhance rehabilitation exercises. We use VR programs developed by Karuna Labs for healthcare.

Woman wearing virtual reality headset uses handheld controllers
VR is experienced through a headset, with handheld controllers used to navigate the virtual environment.

Contact Us

If you are interested in learning more about any of our studies, please complete this form. (Please note that Internet Explorer users should consider disabling their ad blocker or using a different browser to properly access the form.)

You can also follow us on twitter @NYUNeuromod.

If you would like to reach us directly, email us at or call 646-501-7511.